| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 9.232 | 9.117 | 7.091 | 7.924 | 9.171 |
| Total Income - EUR | - | - | - | - | 0 | 9.232 | 9.117 | 7.091 | 7.924 | 9.171 |
| Total Expenses - EUR | - | - | - | - | 0 | 2.456 | 876 | 1.079 | 7.955 | 9.505 |
| Gross Profit/Loss - EUR | - | - | - | - | 0 | 6.775 | 8.241 | 6.012 | -31 | -335 |
| Net Profit/Loss - EUR | - | - | - | - | 0 | 6.498 | 7.967 | 5.853 | -111 | -610 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Vaccinmed Elar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 1.341 | 1.158 | 1.720 | 1.711 |
| Current Assets | - | - | - | - | 42 | 6.816 | 13.095 | 12.790 | 7.671 | 7.346 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 211 | 4 | 215 | 1.068 | 1.062 |
| Cash | - | - | - | - | 42 | 6.606 | 13.091 | 12.575 | 6.603 | 6.284 |
| Shareholders Funds | - | - | - | - | 42 | 6.539 | 9.308 | 10.921 | 4.942 | 4.304 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 0 | 277 | 5.129 | 3.027 | 4.449 | 4.752 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vaccinmed Elar S.r.l.